They have a great product treating cancer with immunotherapy, peer reviewed journal

look into Adamis Pharma, no more speculation, now it's real, two FDA approved meds, two major products, top of the line in comparison of their rivals, for cheaper price, AND WITH NO MUCH COMPETITION!

2023 is going to be very positive for patients of our products and shareholders alike

Their product works (see the mad Pole Piotr’s graphs 😵‍💫) Multi year holds, the bodadem.

We have great data out of a superior product,

They have good products and a solid future.

no more speculation, now it's real, two FDA approved meds, two major products, top of the line in comparison of their rivals, for cheaper price, AND WITH NO MUCH COMPETITION!

14 years later, stand behind and present your product with vigor and passion not an alcoholics enthusiasm. Do.

but even better to see the science underneath the product becoming more and more studied in a variety of ways.

Their product works (see the mad Pole Piotr’s graphs 😵‍💫) Multi year holds, the bodadem.

This share price is a steal with those great Levo results this morning, and their other 3 approved and growing products.

$ENSC 8mil mcap, just patents alone is worth 100mill ++ Product showing better results than OxyContin.

$IVDA is diverse in its revenue streams, Ivedacare as a product line for $BBAI $SOUN $AI $FOXO would be far superior to any of their AI components,

Hot sector, a turnaround story with expanding product range, tested and liked by US Army, partnerships with global leaders in their fields like Redwire and Palantir, what's not to like?